Type1diabetes Clinical Trials

31 recruitingLast updated: June 18, 2026

There are 31 actively recruiting type1diabetes clinical trials across 13 countries. Studies span Not Applicable, Phase 1, Phase 4, Early Phase 1, Phase 2. Top locations include Boston, Massachusetts, United States, Luoyang, Henan, China, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


Type1diabetes Trials at a Glance

31 actively recruiting trials for type1diabetes are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Boston, Luoyang, and Montreal. Lead sponsors running type1diabetes studies include Boston Children's Hospital, Emory University, and Henan University of Science and Technology.

Browse type1diabetes trials by phase

Treatments under study

About Type1diabetes Clinical Trials

Looking for clinical trials for Type1diabetes? There are currently 31 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Type1diabetes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Type1diabetes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Not Applicable

Thrive With Type 1 Diabetes 2026

Type1diabetes
Emory University48 enrolled2 locationsNCT07522866
Recruiting
Not Applicable

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

Type1diabetes
Henan University of Science and Technology82 enrolled1 locationNCT07092761
Recruiting
Not Applicable

Exercise Training and Endothelial Function in Type 1 Diabetes

Type1diabetes
University Hospital, Lille34 enrolled1 locationNCT03528226
Recruiting

Pancreas Ultrasound Imaging in type1 Diabetes

Type1diabetesInsulitisPancreas Inflamed
University of Colorado, Denver50 enrolled1 locationNCT05482321
Recruiting

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

DiabetesType1diabetes
Second Xiangya Hospital of Central South University20,000 enrolled11 locationsNCT05498974
Recruiting
Phase 4

Tirzepatide Use in People With Obesity and Type 1 Diabetes

ObesityType1diabetes
Dasman Diabetes Institute60 enrolled1 locationNCT07096908
Recruiting
Not Applicable

Type 1 Diabetes Virtual Self-management Education and Support

Type1diabetes
Unity Health Toronto580 enrolled9 locationsNCT05756829
Recruiting

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

Type1diabetes
Institut National de la Santé Et de la Recherche Médicale, France180 enrolled2 locationsNCT05054361
Recruiting
Not Applicable

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

Type1diabetes
Henan University of Science and Technology12 enrolled2 locationsNCT07139808
Recruiting

Genetics Of Autoimmunity In Type I Diabetes

Diabetes MellitusDiabetes Mellitus, Type 1Type1 Diabetes Mellitus+1 more
Medical College of Wisconsin4,000 enrolled1 locationNCT03648918
Recruiting

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Type1diabetes
Institut de Recherches Cliniques de Montreal86 enrolled1 locationNCT05258292
Recruiting
Not Applicable

Health Behavior Intervention for Adults With Type 1 Diabetes

Type1diabetes
Emory University300 enrolled1 locationNCT05823142
Recruiting
Phase 4

Diabetes in African Youth

Type1diabetes
University of Minnesota180 enrolled1 locationNCT05454176
Recruiting

Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference

Type1diabetes
Attikon Hospital240 enrolled1 locationNCT06646107
Recruiting

Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

Arterial StiffnessDiabetic NeuropathiesDiabetes Complications+2 more
Steno Diabetes Center Copenhagen400 enrolled1 locationNCT05159856
Recruiting
Phase 1

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

ObesityType1diabetes
Yale University15 enrolled1 locationNCT06105931
Recruiting
Not Applicable

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

HyperinsulinismType2diabetesPre-diabetes+1 more
Azienda Ospedaliero-Universitaria di Parma70 enrolled1 locationNCT05662189
Recruiting
Not Applicable

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

Type1diabetesSevere Hypoglycemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1,000 enrolled1 locationNCT06770621
Recruiting
Phase 1

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

DiabetesType1diabetesT1D
McGill University24 enrolled1 locationNCT06753994
Recruiting
Not Applicable

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

Type1diabetes
Boston Children's Hospital32 enrolled1 locationNCT03710928